![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiLEMojkqDEbG7Z3uwf2nd1BVljHNIdGivaIdqC5nrI0Xag0v0iCtAey3xd3YkT-UgsYDwOh6WlnLQOUcxatF5zootmWFVGg47pAAhxeu3MsxyTByZESyhR3IX98tetApLJN6-80qFlQzUS/s320/domainnamelogo.jpg)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYBIB9Mc5CyP1mwTHgcQTcXkRnPhACQzKP1hhAKZmyNuAPcr0vmvgbRx7WpxQGHeKDRepTHzE1wqguudGQU8P97LmfVq5ZnUIcy9uHYexSuLQkQrlkTpnmbfo_KIGzDaQf7wH1aU2EEgNL/s320/child4.gif)
Medicines for children
Opinions and decisions on PIP applications
EMEA decisions on paediatric investigation plans (PIPs), including deferrals and waivers, and on modification of an agreed PIP
Click on a column heading to sort alphabetically or by date.
'W' - decision granting a waiver in all age groups for all conditions / indications
'P' - decision agreeing on a Paediatric Investigation Plan, with or without partial waiver(s) and or deferral(s)
'PM' – decision on the application for modification of an agreed PIP
abrir aquí para acceder al documento completo:
European Medicines Agency - Human Medicines - Medicines for children - EMEA decisions on paediatric investigation plans (PIPs), including deferrals and waivers, and on modification of an agreed PIP
No hay comentarios:
Publicar un comentario